Purpose of this document - WHO | World Health Organization

IPV mitigates or reduces the risk of cVDPV because it is a trivalent vaccine and uses inactivated, rather than weakened, viruses. IPV also strengthens the immune response to types 1 and 3. After the switch from trivalent to bivalent OPV, IPV will be the only vaccine with … ................
................